1. Home
  2. VTSI vs CUE Comparison

VTSI vs CUE Comparison

Compare VTSI & CUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VirTra Inc.

VTSI

VirTra Inc.

HOLD

Current Price

$4.31

Market Cap

53.2M

ML Signal

HOLD

Logo Cue Biopharma Inc.

CUE

Cue Biopharma Inc.

HOLD

Current Price

$0.27

Market Cap

27.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VTSI
CUE
Founded
1993
2014
Country
United States
United States
Employees
N/A
41
Industry
Miscellaneous manufacturing industries
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
53.2M
27.8M
IPO Year
1999
2017

Fundamental Metrics

Financial Performance
Metric
VTSI
CUE
Price
$4.31
$0.27
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$7.00
$3.00
AVG Volume (30 Days)
28.6K
442.9K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
35.14
EPS
0.09
N/A
Revenue
$16,524,225.00
$9,287,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$13.39
$25.00
P/E Ratio
$45.89
N/A
Revenue Growth
5.57
69.16
52 Week Low
$3.57
$0.23
52 Week High
$7.47
$1.05

Technical Indicators

Market Signals
Indicator
VTSI
CUE
Relative Strength Index (RSI) 48.07 39.65
Support Level $4.25 $0.27
Resistance Level $4.49 $0.36
Average True Range (ATR) 0.19 0.03
MACD 0.01 0.00
Stochastic Oscillator 53.49 14.60

Price Performance

Historical Comparison
VTSI
CUE

About VTSI VirTra Inc.

VirTra Inc is a U.S.-based company that is engaged in the sale and development of the judgmental use of force training simulators and firearms training simulators for law enforcement, military, and commercial uses. It sells simulators and related products across the globe through a direct sales force and international distribution partners. The services provided by the company include installation, training, limited warranties, service agreements, and related support. The company sells and supports the use of force training and marksmanship firearms training systems and accessories for law enforcement, military, or civilian use. Company's The product lany includes simulators, upgrade components, scenarios, scenario software, recoil kits, Threat Fire, and other accessories.

About CUE Cue Biopharma Inc.

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.

Share on Social Networks: